Zacks Investment Research
04 Jun 2026, 16:55 UTC · 4h ago
Is NVST Attractive at 15.1x Forward Earnings?
Search tags
Zacks Investment Research
04 Jun 2026, 16:55 UTC · 4h ago
Search tags
Story key points
4 claims · impact-rated
Envista Corporation reported first quarter 2026 revenue of $705.5 million (up 14.4% YoY) and adjusted diluted EPS of $0.36 (up 50% YoY). — Strong top-line growth and significant profit acceleration provide a fundamental catalyst for stock price appreciation.
+0.60Envista's stock price has risen 22.3% over the past year, significantly outperforming its Zacks sub-industry, which declined 30.9% in the same period. — Relative strength against peers suggests a competitive advantage or a successful turnaround, increasing investor confidence.
+0.30Envista currently trades at 15.1x forward 12-month earnings, representing a discount to the Zacks medical sector (19.6x) and the S&P 500 (22.2x). — A valuation discount relative to broader indices suggests potential for multiple expansion if operational improvements continue.
+0.20Continue reading
6 related stories
Analysts have set a price target of $24 for NVST based on a 16.2x forward 12-month earnings multiple. — The target provides a modest upside from the current price of $22.94, implying limited but positive short-term growth expectations.
+0.10Ticker attribution
Model heads
The company has shown meaningful profit acceleration, solid top-line growth, and is rebuilding investor confidence.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
1 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Newsfile Corp
19m ago
